Retractable Technologies (NYSE:RVP) Coverage Initiated by Analysts at StockNews.com

by · The Markets Daily

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP – Free Report) in a research note released on Saturday morning. The firm issued a hold rating on the stock.

Retractable Technologies Trading Up 2.7 %

NYSE RVP opened at $0.64 on Friday. The company has a market capitalization of $19.16 million, a price-to-earnings ratio of -1.19 and a beta of 1.98. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. Retractable Technologies has a 12 month low of $0.56 and a 12 month high of $1.34. The company’s fifty day moving average price is $0.67 and its two-hundred day moving average price is $0.89.

Hedge Funds Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new position in shares of Retractable Technologies, Inc. (NYSE:RVP – Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Further Reading